Diabetes, Obesity and Metabolism

Cover image for Vol. 17 Issue 5

Accepted Articles (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Edited By: R. Donnelly and A. Garber

Impact Factor: 5.456

ISI Journal Citation Reports © Ranking: 2013: 17/124 (Endocrinology & Metabolism)

Online ISSN: 1463-1326


  1. 1 - 12

    1. Safety and Efficacy of Once Weekly Dulaglutide vs Sitagliptin After Two Years in Metformin-treated Patients with Type 2 Diabetes (AWARD-5): A Randomised, Phase 3 Study

      Ruth S. Weinstock, Bruno Guerci, Guillermo Umpierrez, Michael A. Nauck, Zachary Skrivanek and Zvonko Milicevic

      Accepted manuscript online: 23 APR 2015 02:27AM EST | DOI: 10.1111/dom.12479

    2. Efficacy of a long-acting c-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice

      Corinne G. Jolivalt, Maria Rodriguez, John Wahren and Nigel A. Calcutt

      Accepted manuscript online: 23 APR 2015 02:14AM EST | DOI: 10.1111/dom.12477

    3. You have full text access to this OnlineOpen article
      The Impact on HbA1c of a Biologic Response Based Measure of Medication Adherence

      Gregory A. Nichols, A. Gabriela Rosales, Teresa M. Kimes, Kaan Tunceli, Karen Kurtyka, Panagiotis Mavros and John F. Steiner

      Accepted manuscript online: 16 APR 2015 04:14AM EST | DOI: 10.1111/dom.12476

  2. Original Papers

    1. Two Dose-Ranging Studies with PF-04937319, a systemic partial activator of glucokinase, as add-on therapy to Metformin in Adults with type 2 diabetes

      Neeta B. Amin, Naresh Aggarwal, Denes Pall, Gyorgy Paragh, William S. Denney, Vu Le, Michael Riggs and Roberto A. Calle

      Accepted manuscript online: 16 APR 2015 04:12AM EST | DOI: 10.1111/dom.12474

  3. Invited Review Articles

    1. Probiotics in Reducing the Risk of Gestational Diabetes

      Erika Isolauri, Samuli Rautava, Maria Carmen Collado and Seppo Salminen

      Accepted manuscript online: 16 APR 2015 04:11AM EST | DOI: 10.1111/dom.12475

  4. Original Articles

    1. Counterregulatory hormone responses to hypoglycaemia in subjects with type 1 diabetes following 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

      Thomas R. Pieber, Sigrid Deller, Stefan Korsatko, Lene Jensen, Erik Christiansen, Jesper Madsen and Simon R. Heller

      Accepted manuscript online: 9 APR 2015 02:03AM EST | DOI: 10.1111/dom.12473

    2. You have full text access to this OnlineOpen article
      One year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/mL compared with 100 U/mL in people with type 2 diabetes using basal + meal-time insulin (EDITION 1 12-month randomized trial including 6-month extension)

      Matthew C. Riddle, Hannele Yki-Järvinen, Geremia B. Bolli, Monika Ziemen, Isabel Muehlen-Bartmer, Sophie Cissokho and Philip D. Home

      Accepted manuscript online: 2 APR 2015 07:13AM EST | DOI: 10.1111/dom.12472


  6. Original Articles

    1. Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

      Tim Heise, Ulrike Hövelmann, Lise Brøndsted, Charlotte L. Adrian, Leszek Nosek and Hanne Haahr

      Accepted manuscript online: 1 APR 2015 04:48AM EST | DOI: 10.1111/dom.12468


    1. HDAC3 inhibition improves glycemia and insulin secretion in obese diabetic rats

      Morten Lundh, Thomas Galbo, Steen S. Poulsen and Thomas Mandrup-Poulsen

      Accepted manuscript online: 1 APR 2015 04:47AM EST | DOI: 10.1111/dom.12470

  8. Original Articles

    1. Treatment escalation options for patients with type 2 diabetes after failure of exenatide BID or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) Study

      G. Schernthaner, J. Rosas-Guzmán, F. Dotta, B. Guerci, R. Simó, A. Festa, J. Kiljański, M. Zhou and B. Gallwitz

      Accepted manuscript online: 1 APR 2015 04:46AM EST | DOI: 10.1111/dom.12471

    2. Insulin degludec/insulin aspart produces a dose-proportional glucose-lowering effect in subjects with type 1 diabetes mellitus

      T. Heise, L. Nosek, O. Klein, H. Coester, A.L. Svendsen and H. Haahr

      Accepted manuscript online: 16 MAR 2015 02:11AM EST | DOI: 10.1111/dom.12463


  1. 1 - 12